Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lead | 6 | 2014 | 878 | 1.020 |
Why?
|
Environmental Exposure | 12 | 2024 | 4544 | 0.770 |
Why?
|
Air Pollutants | 7 | 2021 | 2921 | 0.760 |
Why?
|
Patella | 2 | 2014 | 317 | 0.710 |
Why?
|
Nitrogen Dioxide | 3 | 2021 | 538 | 0.690 |
Why?
|
Air Pollution | 5 | 2021 | 2379 | 0.550 |
Why?
|
Glutathione S-Transferase pi | 2 | 2014 | 99 | 0.540 |
Why?
|
Tibia | 2 | 2014 | 1071 | 0.530 |
Why?
|
Respiratory Tract Diseases | 3 | 2024 | 744 | 0.490 |
Why?
|
Lead Poisoning, Nervous System | 1 | 2014 | 12 | 0.480 |
Why?
|
Autophagy | 3 | 2012 | 1349 | 0.470 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 4249 | 0.430 |
Why?
|
Glutathione Transferase | 1 | 2013 | 565 | 0.370 |
Why?
|
Genes, ras | 2 | 2010 | 657 | 0.360 |
Why?
|
Antimitotic Agents | 1 | 2010 | 28 | 0.360 |
Why?
|
Particulate Matter | 9 | 2021 | 2623 | 0.360 |
Why?
|
Chemical Industry | 3 | 2008 | 115 | 0.350 |
Why?
|
Niacinamide | 1 | 2012 | 419 | 0.340 |
Why?
|
Phobic Disorders | 1 | 2012 | 440 | 0.320 |
Why?
|
Phenylurea Compounds | 1 | 2012 | 536 | 0.320 |
Why?
|
Paclitaxel | 3 | 2011 | 1727 | 0.310 |
Why?
|
ras Proteins | 2 | 2011 | 1054 | 0.310 |
Why?
|
Menopause | 2 | 2014 | 1657 | 0.310 |
Why?
|
Spectrometry, X-Ray Emission | 3 | 2014 | 144 | 0.300 |
Why?
|
Lead Poisoning | 1 | 2011 | 318 | 0.300 |
Why?
|
NIH 3T3 Cells | 5 | 2012 | 654 | 0.290 |
Why?
|
Cadmium | 1 | 2008 | 218 | 0.280 |
Why?
|
Pneumonia | 1 | 2019 | 2159 | 0.280 |
Why?
|
Psychometrics | 2 | 2007 | 3060 | 0.280 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 678 | 0.280 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2015 | 1481 | 0.270 |
Why?
|
Korea | 6 | 2009 | 97 | 0.270 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2012 | 5334 | 0.270 |
Why?
|
Oxidative Stress | 2 | 2014 | 3141 | 0.270 |
Why?
|
Iron | 1 | 2014 | 1812 | 0.260 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1150 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-raf | 3 | 2010 | 205 | 0.250 |
Why?
|
Caspase 3 | 3 | 2012 | 730 | 0.240 |
Why?
|
Beta Particles | 1 | 2024 | 52 | 0.240 |
Why?
|
Environmental Pollutants | 1 | 2014 | 1294 | 0.230 |
Why?
|
Indoles | 1 | 2012 | 1832 | 0.230 |
Why?
|
Sirolimus | 1 | 2011 | 1541 | 0.220 |
Why?
|
Employment | 2 | 2007 | 1110 | 0.220 |
Why?
|
Cause of Death | 4 | 2021 | 3714 | 0.210 |
Why?
|
Fibroblasts | 2 | 2010 | 4164 | 0.210 |
Why?
|
Sulfonamides | 1 | 2012 | 1978 | 0.200 |
Why?
|
Occupational Health | 2 | 2008 | 812 | 0.190 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2246 | 0.180 |
Why?
|
Workload | 1 | 2007 | 849 | 0.180 |
Why?
|
Cell Line, Transformed | 3 | 2011 | 861 | 0.180 |
Why?
|
Reward | 2 | 2008 | 980 | 0.180 |
Why?
|
Cognition Disorders | 1 | 2013 | 3967 | 0.160 |
Why?
|
Medicare | 4 | 2021 | 6817 | 0.160 |
Why?
|
Apoptosis | 3 | 2012 | 9507 | 0.160 |
Why?
|
Body Size | 1 | 2021 | 461 | 0.150 |
Why?
|
Pyrenes | 2 | 2009 | 51 | 0.150 |
Why?
|
Metallurgy | 2 | 2009 | 90 | 0.150 |
Why?
|
Electrocardiography | 1 | 2011 | 6378 | 0.140 |
Why?
|
Stress, Psychological | 3 | 2008 | 4527 | 0.140 |
Why?
|
Cell Proliferation | 1 | 2012 | 10438 | 0.130 |
Why?
|
Metals | 1 | 2021 | 711 | 0.130 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2011 | 616 | 0.130 |
Why?
|
Ozone | 1 | 2019 | 499 | 0.120 |
Why?
|
Spectrophotometry, Atomic | 1 | 2014 | 80 | 0.120 |
Why?
|
Air Pollution, Indoor | 1 | 2022 | 930 | 0.110 |
Why?
|
Fetal Blood | 1 | 2021 | 1366 | 0.110 |
Why?
|
Formaldehyde | 1 | 2015 | 360 | 0.110 |
Why?
|
Job Satisfaction | 2 | 2008 | 548 | 0.110 |
Why?
|
Transferrin | 1 | 2014 | 283 | 0.110 |
Why?
|
Heart Rate | 2 | 2015 | 4190 | 0.110 |
Why?
|
Hemochromatosis | 1 | 2014 | 175 | 0.110 |
Why?
|
United States | 8 | 2024 | 72910 | 0.100 |
Why?
|
Mental Status Schedule | 1 | 2013 | 315 | 0.100 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2015 | 579 | 0.100 |
Why?
|
Health Personnel | 1 | 2006 | 3382 | 0.100 |
Why?
|
Bone and Bones | 2 | 2014 | 2559 | 0.100 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 615 | 0.100 |
Why?
|
raf Kinases | 1 | 2012 | 116 | 0.100 |
Why?
|
Depression | 1 | 2012 | 8229 | 0.100 |
Why?
|
Aged | 12 | 2024 | 171234 | 0.100 |
Why?
|
Valine | 1 | 2013 | 410 | 0.100 |
Why?
|
Linear Models | 2 | 2012 | 5872 | 0.090 |
Why?
|
Drug Resistance, Multiple | 1 | 2012 | 255 | 0.090 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.090 |
Why?
|
Occupational Exposure | 2 | 2015 | 1807 | 0.090 |
Why?
|
Middle Aged | 14 | 2024 | 223127 | 0.090 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2010 | 61 | 0.090 |
Why?
|
Autonomic Nervous System | 1 | 2015 | 705 | 0.090 |
Why?
|
Odds Ratio | 3 | 2012 | 9654 | 0.090 |
Why?
|
Petroleum | 2 | 2008 | 82 | 0.090 |
Why?
|
Cohort Studies | 7 | 2024 | 41703 | 0.090 |
Why?
|
Logistic Models | 3 | 2011 | 13276 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 316 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 376 | 0.080 |
Why?
|
Neoplasms | 1 | 2019 | 22343 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13639 | 0.080 |
Why?
|
Genotype | 2 | 2014 | 13034 | 0.080 |
Why?
|
Bangladesh | 2 | 2022 | 745 | 0.080 |
Why?
|
Heart Block | 1 | 2011 | 390 | 0.080 |
Why?
|
Occupational Diseases | 2 | 2008 | 1456 | 0.080 |
Why?
|
Humans | 26 | 2024 | 766432 | 0.080 |
Why?
|
Seasons | 2 | 2019 | 1521 | 0.080 |
Why?
|
Male | 19 | 2024 | 363975 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2538 | 0.080 |
Why?
|
Hypertension | 1 | 2008 | 8614 | 0.080 |
Why?
|
Signal Transduction | 2 | 2011 | 23611 | 0.080 |
Why?
|
Veterans | 2 | 2013 | 2667 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2012 | 1490 | 0.070 |
Why?
|
Female | 19 | 2024 | 396354 | 0.070 |
Why?
|
Age Distribution | 1 | 2014 | 2868 | 0.070 |
Why?
|
Boston | 3 | 2024 | 9333 | 0.070 |
Why?
|
Paternal Exposure | 1 | 2008 | 100 | 0.070 |
Why?
|
Adult | 13 | 2024 | 223253 | 0.070 |
Why?
|
Translations | 1 | 2007 | 84 | 0.070 |
Why?
|
Long QT Syndrome | 1 | 2011 | 473 | 0.070 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2143 | 0.070 |
Why?
|
Color Vision Defects | 1 | 2006 | 28 | 0.070 |
Why?
|
Urban Population | 1 | 2014 | 2038 | 0.070 |
Why?
|
Benzene | 1 | 2006 | 106 | 0.060 |
Why?
|
Heart Conduction System | 1 | 2011 | 991 | 0.060 |
Why?
|
Internal-External Control | 1 | 2007 | 348 | 0.060 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1071 | 0.060 |
Why?
|
Protein Kinases | 1 | 2012 | 1608 | 0.060 |
Why?
|
Estrogen Replacement Therapy | 1 | 2012 | 1205 | 0.060 |
Why?
|
Color Perception | 1 | 2006 | 211 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2746 | 0.060 |
Why?
|
Solvents | 1 | 2006 | 299 | 0.060 |
Why?
|
Infertility, Male | 1 | 2008 | 395 | 0.060 |
Why?
|
Adenine | 1 | 2010 | 992 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1963 | 0.060 |
Why?
|
Phosphorylation | 2 | 2012 | 8300 | 0.060 |
Why?
|
Cooking | 2 | 2022 | 327 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2015 | 2592 | 0.060 |
Why?
|
Habits | 1 | 2024 | 147 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2629 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2059 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10064 | 0.050 |
Why?
|
Transfection | 1 | 2010 | 5750 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2010 | 7866 | 0.050 |
Why?
|
Cell Cycle | 1 | 2011 | 2925 | 0.050 |
Why?
|
Heart Diseases | 1 | 2015 | 2814 | 0.050 |
Why?
|
Mice | 5 | 2012 | 81863 | 0.050 |
Why?
|
RNA Interference | 1 | 2010 | 2825 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3736 | 0.050 |
Why?
|
Pacifiers | 1 | 2021 | 12 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2839 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10740 | 0.050 |
Why?
|
Cell Survival | 1 | 2011 | 5741 | 0.050 |
Why?
|
Puerto Rico | 1 | 2021 | 380 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13486 | 0.040 |
Why?
|
Steel | 2 | 2009 | 27 | 0.040 |
Why?
|
Prospective Studies | 2 | 2014 | 54826 | 0.040 |
Why?
|
Arsenic | 1 | 2021 | 357 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2024 | 59538 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2022 | 870 | 0.030 |
Why?
|
Animals | 5 | 2012 | 168887 | 0.030 |
Why?
|
Health Surveys | 1 | 2007 | 4054 | 0.030 |
Why?
|
Social Support | 1 | 2006 | 2191 | 0.030 |
Why?
|
Pregnancy | 3 | 2022 | 30235 | 0.030 |
Why?
|
Age Factors | 1 | 2012 | 18395 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14760 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2352 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8532 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18075 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2022 | 26388 | 0.020 |
Why?
|
Young Adult | 4 | 2024 | 59928 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12527 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2884 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 2900 | 0.020 |
Why?
|
Child | 4 | 2022 | 80668 | 0.020 |
Why?
|
Color Perception Tests | 1 | 2006 | 12 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1677 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1742 | 0.020 |
Why?
|
Risk Factors | 1 | 2012 | 74828 | 0.010 |
Why?
|
CpG Islands | 1 | 2009 | 1208 | 0.010 |
Why?
|
Inhalation Exposure | 1 | 2006 | 432 | 0.010 |
Why?
|
Nervous System | 1 | 2006 | 542 | 0.010 |
Why?
|
Tobacco Smoke Pollution | 1 | 2007 | 828 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3424 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2718 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36460 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2007 | 6212 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42576 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5789 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2015 | 81588 | 0.010 |
Why?
|
DNA Methylation | 1 | 2009 | 4428 | 0.010 |
Why?
|
Heart Failure | 1 | 2019 | 11816 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10860 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39283 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7840 | 0.010 |
Why?
|
Adolescent | 2 | 2009 | 88898 | 0.010 |
Why?
|
Diet | 1 | 2007 | 8085 | 0.000 |
Why?
|
Time Factors | 1 | 2008 | 40116 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 26294 | 0.000 |
Why?
|
Risk Assessment | 1 | 2006 | 24272 | 0.000 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_